These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 347908)

  • 21. Somatostatin and the endocrine pancreas.
    Gerich JE
    Curr Top Mol Endocrinol; 1976; 3():127-43. PubMed ID: 211005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative effects of somatostatin and two somatostatin analogues on the release of insulin, glucagon and growth hormone.
    Efendić S; Luft R; Sievertsson H
    FEBS Lett; 1975 Oct; 58(1):302-5. PubMed ID: 1225595
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of glucagon and insulin secretion from the perfused rat pancreas by a B-cell-selective somatostatin analog.
    Weir GC; Schwarz JA; Mathe CJ
    Metabolism; 1980 Jan; 29(1):68-70. PubMed ID: 6986012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue.
    Long RG; Barnes AJ; Adrian TE; Mallinson CN; Brown MR; Vale W; Rivier JE; Christofides ND; Bloom SR
    Lancet; 1979 Oct; 2(8146):764-7. PubMed ID: 90860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin (growth hormone-release inhibiting hormone).
    Gomez-Pan A; Hall R
    Clin Endocrinol Metab; 1977 Mar; 6(1):181-200. PubMed ID: 196795
    [No Abstract]   [Full Text] [Related]  

  • 27. Observations on the growth hormone, insulin, and glucagon release-inhibiting activities of somatostatin analogues.
    Coy DH; Meyers C; Arimura A; Schally AV; Redding TW
    Metabolism; 1978 Sep; 27(9 Suppl 1):1407-10. PubMed ID: 683009
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical applications of somatostatin analogs.
    Marbach P; Neufeld M; Pless J
    Adv Exp Med Biol; 1985; 188():339-53. PubMed ID: 2863941
    [No Abstract]   [Full Text] [Related]  

  • 29. Somatostatin: a review of its effects especially in human beings.
    Hansen AP; Lundbaek K
    Diabete Metab; 1976 Dec; 2(4):203-18. PubMed ID: 190058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in rats.
    Grant N; Clark D; Garsky V; Jaunakais I; McGregor W; Sarantakis D
    Life Sci; 1976 Sep; 19(5):629-31. PubMed ID: 957897
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effects of somatostatin in acromegaly].
    Schaison G; Roger M; Milhaud G
    Nouv Presse Med; 1976 Mar; 5(10):629-32. PubMed ID: 772591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New horizons in our knowledge of diabetes mellitus.
    Levine R
    J Am Geriatr Soc; 1971 Nov; 19(11):897-908. PubMed ID: 4949263
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypothesis: physiologic role of pancreatic somatostatin and the contribution of D-cell disorders to diabetes mellitus.
    Unger RH; Ipp E; Schusdziarra V; Orci L
    Life Sci; 1977 Jun; 20(12):2081-5. PubMed ID: 329036
    [No Abstract]   [Full Text] [Related]  

  • 34. Somatostatin--clinical implications.
    Ciba Found Symp; 1976; 41():313-50. PubMed ID: 780078
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.
    Taborsky GJ; Smith PH; Porte D
    Am J Physiol; 1979 Feb; 236(2):E123-8. PubMed ID: 369388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues.
    Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET; Sandler S
    Regul Pept; 2007 Jan; 138(1):1-9. PubMed ID: 16935361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of glucagon release by addition of anti-stomatostatin serum to islets of Langerhans in vitro.
    Barden N; Lavoie M; Dupont A; Côté J; Côté JP
    Endocrinology; 1977 Aug; 101(2):635-8. PubMed ID: 328268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of somatostatin and its analogues in the pathogenesis and treatment of diabetes mellitus.
    Gerich JE
    Metabolism; 1990 Sep; 39(9 Suppl 2):52-4. PubMed ID: 1976221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibitory effect of the analog D5-F-TrP8-D-Cys14 somatostatin on the arginine induced release of insulin, growth hormone and glucagon, in normal human beings.
    González-Bárcena D; Mendoza F; Graef A; Medina R; Comaru-Schally AM; Schally AV
    Arch Invest Med (Mex); 1985; 16 Suppl 3():105-14. PubMed ID: 2878649
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of glucagon in the endogenous hyperglycemia of diabetes mellitus.
    Unger RH; Orci L
    Annu Rev Med; 1977; 28():119-30. PubMed ID: 324351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.